FMR LLC 13D and 13G filings for Trevi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 11:40 am Purchase | 2026-03-31 | 13G | TREVI THERAPEUTICS INC TRVI | FMR LLC | 8,038,061 6.300% | 1,538,052 (+23.66%) | Filing |
| 2026-02-05 1:40 pm Purchase | 2025-12-31 | 13G | TREVI THERAPEUTICS INC TRVI | FMR LLC | 6,500,009 5.100% | 6,500,009 (New Position) | Filing |